Search
for
Sort by
Research 301–330 of 1000+
- Role of Insulin Resistance in Males with Early Androgenetic Alopecia
- Inositol and FSH: A new frontier for the androgenetic alopecia treatment
- Risks for metabolic syndrome and cardiovascular diseases in both male and female patients with androgenetic alopecia
- Faculty Opinions recommendation of Higher body mass index is associated with greater severity of alopecia in men with male-pattern androgenetic alopecia in Taiwan: a cross-sectional study.
- The role of hormones in female androgenetic alopecia: focus on menopause
- Evaluation of Insulin Resistance Markers in Polycystic Ovary Syndrome Patients Receiving Metformin, Finasteride or Both
- Enhanced polycystic ovary syndrome screening: incorporating population and symptom-specific scales into a validated questionnaire and assessment of the syndrome’s associated factors: an analytical cross-sectional study
- Homeostatic maintenance of the murine corneal epithelium in pathophysiological contexts
- Chilblains in Turkey: a case-control study
- The Associations Between Serum Concentrations of Irisin and Glucose-dependent Insulinotropic Polypeptide with Body Mass Index Among Women with and Without Polycystic Ovary Syndrome
- The Relationship Between Acne and Other Hyperandrogenism Signs
- A STUDY OF CLINICAL PARAMETERS IN THE DIAGNOSIS OF POLYCYSTIC OVARIAN SYNDROME
- Evaluation of Effectiveness of Bio-Micro Injection in Treating Alopecia Universalis: A Non-Randomized Interventional Study
- Screening for gestational diabetes: usefulness of clinical risk factors
- Effect of metformin on clinical and biochemical hyperandrogenism in adolescent girls with type 1 diabetes
- Clinical Effects of Glucagon-Like Peptide-1 Agonist Use for Weight Loss in Women With Polycystic Ovary Syndrome: A Scoping Review
- Hair Cortisol Concentration in Healthy Children and Adolescents Is Related to Puberty, Age, Gender, and Body Mass Index
- Acne severity and the Global Acne Grading System in polycystic ovary syndrome
- The guidelines issued by the European Society for Human Reproduction and Embryology and the American Society for Reproductive Medicine regarding the induction of ovulation with metformin in patients with the polycystic ovary syndrome potentially require reconsideration
- Capability, Opportunity, and Motivation—Identifying Constructs for Increasing Physical Activity Behaviours in Women with Polycystic Ovary Syndrome (PCOS)
- Serum Preptin and Amylin Levels with Respect to Body Mass Index in Polycystic Ovary Syndrome Patients
- Cutaneous manifestations in obese patients and non-obese controls in a tertiary care centre: a case-control study
- Multidisciplinary screening and diagnosis of obesity related diseases: an Arabic Association for the Study of Diabetes and metabolism position statement (AASD)
- Polycystic Ovary Syndrome: Impact of Lifestyle Modifications Among Overweight and Obese Infertile Women
- Comparison of hormonal levels between infertile PCOS and non-PCOS females
- Association of Myo-Inositol and Microlipodispersed Magnesium in Androgen-Dependent Dermatological Diseases: A Retrospective Study
- A Study on The Proportion/Hospital Based Prevalance of Non-Alcoholic Fatty Liver Disease (NAFLD) in Diagnosed Cases of Polycystic Ovarian Syndrome (PCOS) Seen in A Tertiary Care Centre of Bihar
- Inositol and FSH: A new frontier for the androgenetic alopecia treatment in PCOS
- Paneth Cells in Intestinal Homeostasis and Tissue Injury
- The clinical characteristics and etiological study of nonalcoholic fatty liver disease in Chinese women with PCOS.